We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

SD BIOSENSOR

SD BIOSENSOR develops immunological and molecular diagnostics and blood glucose self-monitoring systems, glycated hem... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Rapid Tests Evaluated in the Management of Dengue Fever

By LabMedica International staff writers
Posted on 12 Nov 2020
Print article
Image: The STANDARD F Dengue IgM/IgG FIA qualitatively analyzes Dengue virus specific IgM and IgG antibodies in serum, plasma and whole blood using fluorescent immunoassay (Photo courtesy of SD Biosensor).
Image: The STANDARD F Dengue IgM/IgG FIA qualitatively analyzes Dengue virus specific IgM and IgG antibodies in serum, plasma and whole blood using fluorescent immunoassay (Photo courtesy of SD Biosensor).
Dengue is a mosquito-borne infection caused by four distinct viruses (DENV 1-4) which belong to the flavivirus genus and may lead to diverse outcomes. The disease can be asymptomatic in about 75% of cases, causing Dengue fever (DF), or result in severe dengue. Dengue is common in more than 120 countries.

The laboratory diagnosis, essential to recognize dengue cases, is based on viral isolation, serological tests, and detection of viral RNA. Isolation is cumbersome, requires high biocontainment and often takes too long for clinical management. The use of rapid diagnostic tests (RDTs) may be of help as a preliminary user-friendly quick assay to facilitate dengue diagnosis.

Infectious Disease specialists at the Lazzaro Spallanzani National Institute for Infectious Diseases (Rome, Italy) retrospectively reviewed patients with dengue-like symptoms who spontaneously sought treatment in healthcare units of Lazio Region (Central Italy) from January 2014 through July 2019. DF diagnosis was confirmed at the Regional Reference Laboratory in 102 out of 804 (12.7%) febrile patients tested. RDTs have been performed on samples derived from 651 individuals, representing the 80.9% of possible cases tested at the Institute.

A colorimetric test detecting the NS1 viral antigen and anti-DENV IgM and IgG (SD Bioline Dengue Duo, Abbott Diagnostics, Abbott Park, IL, USA) was used as preliminary assay between January 2014 and December 2017. From August 2018, the colorimetric test was replaced by fluorimetric RDTs: STANDARD F Dengue NS1 Ag FIA + STANDARD F Dengue IgM/IgG FIA (SD Biosensor, Gyeonggi-do, Republic of Korea).

Two molecular assays to detect DENV RNA were used: a real time RT-PCR (DENV-1-4 Real-Time RT-PCR Multiplex Assay, developed in 2019 by Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA), and a modified Pan-flavivirus specific nested PCR targeting NS5 region. In addition, multiple indirect immunofluorescence assays (IFA, Flavivirus Mosaic 2 or Arboviral Fever Mosaic-2, IgM and IgG (Euroimmun, Lübeck, Germany) were performed for specific IgM and IgG titers measurement and differential diagnosis.

The investigators reported that the combined use of NS1 and IgM/IgG RDT for the detection of acute dengue cases resulted in an overall sensitivity and specificity of 87.2% and 97.9% for Colorimetric RDT, and 96.2% and 96.2% for Fluorimetric RDT. NS1 was the most reliable marker of acute infection, while IgM resulted falsely positive in nine samples, including sera derived from two Zika and four non-arbovirus infected patients.

The authors concluded that although confirmatory tests are still necessary, their experience strongly supported the use of combined NS1 and IgM/IgG rapid dengue tests as first line tools for prompt case identification. The use of these tests aids the clinical management, surveillance activities, and vector control strategies. The study was published on October 1, 2020 in the International Journal of Infectious Diseases.

Related Links:
Lazzaro Spallanzani National Institute for Infectious Diseases
Abbott Diagnostics
SD Biosensor
Centers for Disease Control and Prevention
Euroimmun



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.